HPLC (High Performance Liquid Chromatography) detection method for base toxin impurity DDQ in agomelatine
Through the optimization of HPLC detection method, the difficulty of DDQ detection in agomelatine is solved, high sensitivity and low detection limits are achieved, and the safety and quality control of the drug are ensured.
Patent Information
- Application Number
- CN202411238644.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-04
- Publication Date
- 2024-11-22
AI Technical Summary
The prior art cannot effectively detect DDQ of genotoxic impurity in agomelatine, resulting in difficulty and low detection limits, affecting drug safety.
The HPLC detection method is used to achieve accurate detection of DDQ by optimizing dilution and chromatographic conditions, including using Waters XBridge C18 chromatographic columns, gradient elution procedures and specific dilution preparation.
It provides a method that is easy to operate, has high sensitivity, low detection limit and good repeatability, which can accurately detect genotoxic impurities of DDQ in agomelatine to meet drug quality control and evaluation needs.
Smart Images

Figure CN119000945A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of drug analysis, and particularly relates to a HPLC detection method for genotoxic impurity DDQ in agomelatine. Background Art
[0002] Agomelatine is a new type of antidepressant. It is a potent agonist of two melatonin receptors (MT1 and MT2) and has an additional antagonist effect on 5-HT2C. Chemical name: N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, molecular formula: C 15 H 17 NO2, molecular weight: 243.31, its chemical structure is:
[0003]
[0004] The synthetic route of agomelatine is shown in Figure 1 , wherein the intermediate AG-2 is dehydrogenated to obtain the intermediate AG-3, using 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) as a dehydrogenation reaction reagent.
[0005]
[0006] 2,3-Dichloro-5,6-dicyanobenzoquinone (DDQ) is a highly active strong oxidizing agent, which is widely used in the dehydrogenation of compounds, especially for steroidal compounds, and has good selectivity. It is an indispensable oxidizing agent in the current steroid industry. Its structural formula is:
[0007]
[0008] According to the production process of agomelatine, DDQ is a dehydrogenation reagent for the preparation of intermediates. From the structure of DDQ, it can be seen that DDQ contains halogenated olefins and quinone structures. The EU JRC clearly pointed out in the article "Development of structural alerts for the in vivo micronucleus assay in rodents" that halogenated olefins and quinones are warning structures. The prediction software (Expert Rule-Based and Statistical-Based) for bacterial mutagenicity was used, and the results showed that DDQ is a potential mutagenic impurity. The European Medicines Agency (EMEA), the US Food and Drug Administration (FDA) and the International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) have successively issued guidance documents on the control of genotoxic impurities, recommending the use of the threshold of toxicological concern (TTC) to control the risk of medication, and to control mutagenic impurities at a reasonable level to reduce the risk of carcinogenesis to humans. Therefore, it is necessary to study DDQ in agomelatine and formulate a reasonable control strategy. Based on the TTC calculation method, the acceptable intake of TTC for the most stringent lifelong administration is 1.5 μg / day. According to the agomelatine instructions, the maximum daily dose is 50 mg, so the limit of DDQ should not exceed 1.5 μg / 50 mg = 0.003%, i.e. 30 ppm. DDQ has poor stability, low limit, and difficult detection. Currently, there is no detection method that can detect the genotoxic impurity DDQ in agomelatine API.
[0009] In order to ensure the safety of patients' medication, the genotoxic impurity DDQ in agomelatine needs to be strictly controlled and accurately detected. Therefore, it is necessary to develop a detection method for the genotoxic impurity DDQ in agomelatine with simple operation, high sensitivity, low detection limit and good repeatability. Summary of the invention
[0010] The technical problem to be solved by the present invention is to provide a method for detecting DDQ, a genotoxic impurity in agomelatine. The method can solve the problem of poor DDQ peak shape by controlling and selecting a suitable diluent. The method is easy to operate and has strong versatility, and can be used for quality control and evaluation of agomelatine raw materials.
[0011] To achieve the above-mentioned object of the invention, the present invention comprises the following steps:
[0012] (1) Preparation of test solution;
[0013] (2) Preparation of reference solution;
[0014] (3) Preparation of blank solution, the blank solution is selected from methanol-water-phosphoric acid (55:45:1), calculated by volume ratio;
[0015] (4) Determination method: Take the blank solution, reference solution, and test solution mentioned above, inject them into a high performance liquid chromatograph, record the chromatogram, and calculate the impurities according to the external standard method;
[0016] Furthermore, in the step (1), the test solution is prepared by taking an appropriate amount of homemade agomelatine raw material, dissolving it in a diluent and diluting it to prepare a 5 mg / ml solution.
[0017] Further, in step (2), the reference solution is prepared by taking an appropriate amount of DDQ reference substance, dissolving it in a diluent and diluting it to form a 0.15 μg / ml solution.
[0018] Furthermore, the chromatographic conditions of the high performance liquid phase detection method in step (4) are selected from:
[0019] Chromatographic column: Waters XBridge C18, column length 100-250 mm;
[0020] Column temperature: 45-60°C; flow rate: 0.8-1.2 ml / min; injection volume: 10-25 μl; sample plate temperature: 5-10°C;
[0021] UV detector: 280~300nm;
[0022] The diluent is selected from methanol-water-phosphoric acid (55:45:1), calculated by volume ratio;
[0023] Mobile phase A is selected from 0.08% to 0.15% trifluoroacetic acid solution
[0024] The mobile phase B is selected from acetonitrile; the mobile phase A and the mobile phase B are used in different volume ratios for gradient elution.
[0025] Furthermore, the gradient elution program is: 0-5 min, 83%-87% A, 13%-17% B; 5-12 min, 83%-87%-20% A, 13%-17%-80% B; 12-20 min, 20% A, 80% B; 20-20.1 min, 20%-85% A, 80%-15% B; 21.1-30 min, 83%-87% A, 13%-17% B.
[0026] Furthermore, the chromatographic conditions are: column temperature of 48-52°C; flow rate of 0.9-1.1 ml / min, and detection wavelength of UV detector of 288-292 nm.
[0027] Furthermore, the chromatographic column model used was 4.6 mm × 150 mm, 3.5 μm, the column temperature was 50°C; the flow rate was 1.0 ml / min, the injection volume was 20 μl, the sample plate temperature was 10°C, the UV detector detection wavelength was 290 nm, the mobile phase A was 0.1% trifluoroacetic acid solution, and the mobile phase B was acetonitrile.
[0028] Beneficial effects of the present invention
[0029] 1. The present invention provides for the first time an HPLC method for detecting the genotoxic impurity DDQ in agomelatine. The analytical method of the present invention is determined by optimizing and screening the diluent and chromatographic conditions.
[0030] 2. This method has the advantages of easy operation, strong versatility, good specificity, high sensitivity, low detection limit, good reproducibility, accurate and reliable data, etc. It can be used for the quality control and evaluation of DDQ genotoxic impurities in agomelatine raw materials to meet the needs of research and development and production. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 Blank spectrum;
[0032] Figure 2 Example 3DDQ reference solution spectrum;
[0033] Figure 3 Agomelatine test solution spectrum;
[0034] Figure 4 Spectrum of agomelatine spiked test solution;
[0035] Figure 5 DDQ linear relationship diagram
[0036] Figure 6 Example 12DDQ reference solution spectrum DETAILED DESCRIPTION
[0037] The specific implementation modes of the present invention are described in detail below with reference to the accompanying drawings.
[0038] Experimental instrument: Shimadzu LC-20AD high performance liquid chromatograph, equipped with UV detector; diluent v / v / v: methanol-water-phosphoric acid (55:45:1)
[0039] Example 1 Preparation of agomelatine test solution, blank solution and reference solution
[0040] Blank solution: same as diluent
[0041] Preparation of test solution: Take an appropriate amount of homemade agomelatine raw material, dissolve it in diluent and dilute it to make a 5 mg / ml solution as the test solution.
[0042] Preparation of reference solution: Take an appropriate amount of DDQ reference substance, dissolve it in diluent and dilute it to make a 0.15 μg / ml solution as the reference solution.
[0043] Example 2—Chromatographic Assay
[0044] Take the blank solution, reference solution and test solution respectively, inject them into the high performance liquid chromatograph, record the chromatogram, calculate the impurities according to the external standard method, and analyze the samples according to the following chromatographic conditions:
[0045] Chromatographic column: Waters XBridge C18, 4.6mm×150mm, 3.5μm or other chromatographic columns with equivalent performance;
[0046] Flow rate: 1.0ml / min
[0047] Detection wavelength: 290nm
[0048] Column temperature: 50°C
[0049] Injection volume: 20 μl
[0050] Sample plate temperature: 10°C
[0051] The mobile phase A is selected from 0.1% trifluoroacetic acid solution; the mobile phase B is selected from acetonitrile; the mobile phase A and the mobile phase B are used in different volume ratios for gradient elution according to Table 1.
[0052] Table 1: Gradient elution program
[0053] Time, minutes 0 5 12 20 20.1 30 A% 85 85 45 20 20 90 B% 15 15 55 80 80 10
[0054] Example 3 Specificity Investigation
[0055] Prepare a spiked test solution with a DDQ limit of 30 ppm. The blank solution spectrum is shown in Figure 1 , the reference solution spectrum is shown in Figure 2 , the spectrum of the test solution is shown in Figure 3 , the spectrum of the spiked test solution is shown in Figure 4 , the results are shown in Table 2. The blank does not interfere with the detection of DDQ in the sample.
[0056] Table 2: Specificity results
[0057]
[0058] Example 4 Investigation of detection limit and quantification limit
[0059] The reference solution was diluted step by step and its signal-to-noise ratio was tested. The signal-to-noise ratio was about 10:1 as the quantification limit, about 3:1 as the detection limit, 2 injections at the detection limit concentration, and 6 injections at the quantification limit. The results are shown in Table 3. This method can detect DDQ at the 2 ppm level in agomelatine with high sensitivity.
[0060] Table 3: Detection limit and quantification limit results
[0061]
[0062] Example 5 Linear Relationship Investigation
[0063] The impurity DDQ was selected within the limit range of LOQ to 36ppm at 5 points. The above chromatographic conditions were used to determine the concentrations and the corresponding peak areas, and regression curves were drawn to calculate the regression equation and correlation coefficient. The results are shown in Table 4, and the DDQ linear relationship diagram is shown in Figure 5 , DDQ has a good linear relationship in the range of 0.0302~0.1809μg / ml.
[0064] Table 4: Linearity results
[0065]
[0066] Example 6 Accuracy Investigation
[0067] The recoveries of DDQ in agomelatine at the limit levels of 30% (9 ppm), 80% (24 ppm), 100% (30 ppm) and 120% (36 ppm) were investigated. Three replicates were run at each concentration level. The results are shown in Table 5. The recoveries were all between 60% and 140%, and the RSD was less than 30.0%, indicating that the data of this method was accurate and reliable.
[0068] Table 5: Accuracy results
[0069]
[0070] Example 7 Injection Precision Study
[0071] The reference solution was injected 6 times continuously and the chromatogram was recorded. The results are shown in Table 6. The RSD of the DDQ peak area after 6 consecutive injections was less than 10%, indicating that the injection precision of this method was good.
[0072] Table 6: Injection precision results
[0073] Impurity Name 1# 2# 3# 4# 5# 6# RSD(%) DDQ 8369 8317 8379 8334 8518 8216 1.2
[0074] Example 8 Repeatability Study
[0075] Six test sample solutions and spiked test sample solutions were prepared in parallel, where the DDQ added to the spiked test sample was at a level of 30 ppm. The results are shown in Tables 7 and 8. The RSDs of the impurity contents in the six background test samples and the spiked test sample solutions were all less than 20%, and the recoveries of the impurities in the six spiked test samples were all between 70% and 130%, with RSDs less than 20.0%, indicating that the method had good repeatability.
[0076] Table 7: Repeatability results
[0077]
[0078] Table 8: Recovery results of spiked test products
[0079]
[0080] Example 9 Durability Study
[0081] Use normal conditions, different wavelengths, flow rates, column temperatures and initial ratios of mobile phases for the predetermined tests, and the parameters for change are shown in Table 9. After the instrument system is stable, test the test solution and the reference solution. Only one parameter is changed each time, and the system suitability (theoretical plate number and peak area RSD) and the ratio of the test sample content to the normal result under the conditions of each parameter change are statistically analyzed. The results of the method durability experiment are shown in Table 10. When the chromatographic conditions change slightly, the RSD of the 6-pin peak area of the reference solution is less than 10%, and the theoretical plate number is not less than 2000 calculated according to the impurity DDQ peak. Impurity DDQ is not detected in the test solution.
[0082] Table 9: Durability variation parameters
[0083] Changing parameters Variation 1 Normal level Variation 2 Wavelength nm 288 290 292 Flow rate ml / min 0.9 1.0 1.1 Column temperature ℃ 48 50 52
[0084] Table 10: Durability results
[0085]
[0086] Example 10 Stability Study
[0087] Samples were injected according to the test method requirements, and the reference solution, background test solution, and spiked test solution (30ppm) were tested at different times (at least 48 hours). The results are shown in Table 11. The reference solution was stable after 56 hours at 10°C; the background test solution and spiked test solution were stable after 50 hours at 10°C.
[0088] Table 11: Stability results
[0089]
[0090]
[0091] Example 11 - Test sample determination
[0092] According to the test method requirements, three batches of agomelatine test solutions were tested. The results are shown in Table 12. No DDQ was detected.
[0093] Table 12: Typical sample test results
[0094] Test product DDQ Test sample 1 Not detected Test sample 2 Not detected Test sample 3 Not detected
[0095] Example 12 Methodology Development - Dilution Selection
[0096] The chromatographic conditions were the same as those in Example 2. The effects of different diluents on the recovery rate and peak shape of DDQ were investigated. The results are shown in Table 13.
[0097] Table 13: Dilution selection considerations
[0098]
[0099] Conclusion: The recovery rate and peak shape of DDQ are different when using different diluents. After changing the diluent to methanol-water-phosphoric acid (55:45:1), the recovery rate and peak shape of DDQ can be improved on the basis of dissolving agomelatine raw material, and the recovery rate is close to 100%. For details, see Figure 6 .
[0100] Example 13 Methodology Development - Mobile Phase and Chromatographic Column Selection
[0101] The chromatographic conditions were the same as those in Example 2. The effects of different mobile phases and chromatographic columns on the peak shape of DDQ were investigated. Mobile phase A was selected from phosphoric acid, trifluoroacetic acid, ammonia water, and potassium dihydrogen phosphate, and mobile phase B was selected from methanol and acetonitrile. The peak shapes of DDQ on different chromatographic columns were investigated. The results are shown in Table 14.
[0102] Table 14 Mobile phase and chromatographic column model investigation
[0103]
[0104]
[0105] Conclusion: The peak shape of DDQ is different when using different mobile phases and chromatographic columns. The peak shape of DDQ can be improved by selecting 0.1% trifluoroacetic acid solution / acetonitrile system and using Waters XBridge C18, 4.6mm×150mm, 3.5μm chromatographic column. The tailing factor is close to 1.0 and the theoretical plate number is relatively high.
[0106] Through the above Examples 1 to 10, the method was investigated for specificity, detection limit and quantification limit, linearity, accuracy, injection precision, repeatability, durability and stability. All tests met the requirements, proving that the method is suitable for the detection and analysis of DDQ in agomelatine.
[0107] The above is only a preferred embodiment of the present invention. It should be pointed out that a person skilled in the art can make several modifications and improvements without departing from the inventive concept of the present invention, which all belong to the protection scope of the present invention.
Claims
1. A HPLC detection method for the genotoxic impurity DDQ in agomelatine, characterized in that: The steps include: (1) Preparation of test solution; (2) Preparation of reference solution; (3) Preparation of blank solution; (4) Determination method: Take the blank solution, reference solution and test solution mentioned above respectively, inject them into high performance liquid chromatography, record the chromatogram, and calculate the impurities according to the external standard method.
2. The HPLC detection method according to claim 1, characterized in that In the step (1), the sample preparation is selected from the step of dissolving an appropriate amount of homemade agomelatine raw material with a diluent and diluting it to prepare a 5 mg / ml solution.
3. The HPLC detection method according to claim 1, characterized in that The reference substance solution of step (2) is prepared by taking an appropriate amount of DDQ reference substance, dissolving it in a diluent and diluting it to prepare a 0.15 μg / ml solution.
4. The HPLC detection method according to claim 1, characterized in that The blank solution of step (3) is prepared by methanol-water-phosphoric acid (55:45:1), calculated by volume ratio.
5. The HPLC detection method according to claim 1, characterized in that The chromatographic conditions of the high performance liquid phase in step (4) are selected from: Chromatographic column: Waters XBridge C18, column length 100-250 mm; Column temperature: 45-60°C; flow rate: 0.8-1.2 ml / min; injection volume: 10-25 μl; sample plate temperature: 5-10°C; UV detector: 280~300nm; The diluent is selected from methanol-water-phosphoric acid (55:45:1), calculated by volume ratio; Mobile phase A is selected from 0.08% to 0.15% trifluoroacetic acid solution Mobile phase B is selected from acetonitrile; The mobile phase A and the mobile phase B were used in different volume ratios for gradient elution.
6. The HPLC detection method according to claim 5, characterized in that The gradient elution procedure is: 。 7. The HPLC detection method according to claim 5, characterized in that The chromatographic conditions are as follows: column temperature is 48-52° C.; flow rate is 0.9-1.1 ml / min; and detection wavelength of UV detector is 288-292 nm.
8. The HPLC detection method according to claim 5, characterized in that The chromatographic column model used was 4.6 mm × 150 mm, 3.5 μm, and the column temperature was 50°C; the flow rate was 1.0 ml / min, the injection volume was 20 μl, and the sample plate temperature was 10°C; the UV detector detection wavelength was 290 nm, the mobile phase A was 0.1% trifluoroacetic acid solution, and the mobile phase B was acetonitrile.
